In a striking revelation that underscores growing public unease, recent findings have exposed a profound decline in confidence regarding the safety of the U.S. food supply, marking a historic low in public sentiment that demands urgent attention. This alarming trend, captured in a comprehensive
AstraZeneca, a major UK-based pharmaceutical company, has committed to a transformative $50 billion investment in its U.S. operations. This strategic initiative focuses on enhancing its manufacturing and research capabilities, aiming to secure a significant share of the American market by
COIM USA's recent acquisition of a 20-acre rail-served property at TexAmericas Center marks a significant milestone in sustainable chemical manufacturing. Situated in one of the largest mixed-use industrial parks in the United States, this strategic location will play a pivotal role in expanding
In recent years, the U.S. pharmaceutical industry has been navigating the complex landscape of international trade policies and their implications on drug manufacturing and pricing. Central to this discussion are the tariffs proposed by the Trump administration, which have placed a spotlight on the
Nigeria's strides toward establishing a robust food security framework have gained notable momentum, thanks to the dedicated efforts of entities like Olam Agri. Marking 15 years since their acquisition of Crown Flour Mills, the company has showcased a remarkable evolution in the milling industry.
Orion Minerals Limited is steadily progressing its South African copper and zinc projects, primarily focusing on the Prieska Copper Zinc Mine (PCZM) and the Okiep Copper Project (OCP). As detailed in Orion's June 2025 Quarterly Activities Report, the firm is moving toward production that is
